Search Results 1671-1680 of 16260 for Gout
The purpose of this story is to identify key radiographic variables that are predictive of symptomatic improvement in those patients undergoing endobronchial ...
The purpose of this study is to evaluate the sasfety and effectiveness of MK-7264 in reducing cough frequency as measured over a 24-hour period. Participation ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Thomas Brott, M.D., a Mayo Clinic neurologist, still vividly remembers the first moment he saw his research making a difference for patients. It was 1987, and, ...
And it is a slowly growing but fairly aggressive tumor. Now the treatment for a chordoma is an aggressive surgery where we take the tumor out in one piece.
About this study. The PHAR is a multicenter, prospective registry of newly evaluated patients at PHCCs in the United States who have either PAH or CTEPH.
To study the safety and effectiveness of multiple-doses of tralokinumab on pulmonary function in adults with mild to moderate idiopathic pulmonary fibrosis (IPF) ...
Their crucial work saves lives every day. Let Mayo Clinic researchers know they're appreciated with a quick message.
Your gift holds great power – donate today! ... Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.
Illnesses caused by disease-infected ticks, mosquitoes and fleas have tripled in the U.S. in recent years, according to a report from the Centers for ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.